Regulation of mouse chondrocyte differentiation by CCAAT/enhancer-binding proteins

Biomedical Research
Tomotake OkumaTaku Saito

Abstract

CCAAT/enhancer-binding protein (C/EBP) β regulates chondrocyte differentiaion and proliferation during endochondral ossification. However, expression and function of other C/EBP family members in chondrocytes have not been fully understood. To understand the comprehensive regulation of chondrocyte differentiation by C/EBPs, we initially examined their expression levels. Among four members (C/EBPα, C/EBPβ, C/EBPδ and C/EBPε) with transactivation domain, expression of Cebpb and Cebpd was abundant compared to Cebpa, while Cebpe was hardly expressed in mouse isolated chondrocytes. Doxycycline (DOX)-inducible overexpression of each of the three C/EBPs (C/EBPα, C/EBPβ and C/EBPδ) in ATDC5 cells suppressed expressions of early differentiation markers including Col2a1, aggrecan and Sox9, enhanced those of late differentiation markers including Mmp13, Vegfa and Col10a1, and decelerated cell proliferation, indicating their overlapped functions in chondrocytes. In contrast, DOX-inducible overexpression of A-CEBP, which exerts a dominant-negative effect against all C/EBPs, increased expressions of early differentiation markers and decreased those of late differentiation markers. Finally, microarray and gene ontology analyses showed that A-...Continue Reading

References

Jul 1, 1988·Genes & Development·W H LandschulzS L McKnight
Aug 25, 1995·Science·N D WangG J Darlington
Dec 16, 1997·Proceedings of the National Academy of Sciences of the United States of America·R YamanakaK G Xanthopoulos
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·B WilmK Imai
Sep 2, 1998·Proceedings of the National Academy of Sciences of the United States of America·E SterneckP F Johnson
Aug 30, 2001·Proceedings of the National Academy of Sciences of the United States of America·S OyadomariM Mori
May 15, 2002·The Biochemical Journal·Dipak P Ramji, Pelagia Foka
May 16, 2003·Nature·Henry M Kronenberg
Jun 6, 2006·Nature Immunology·Hideyo HiraiDaniel G Tenen
Aug 21, 2008·Nature Protocols·Marjolaine GossetClaire Jacques
Dec 17, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steffen KoschmiederDaniel G Tenen
Oct 21, 2010·Cancer Research·Peter L J de KeizerBoudewijn M T Burgering
Sep 16, 2011·Annals of the Rheumatic Diseases·Hidetoshi TsushimaYukihide Iwamoto
Mar 1, 2012·Cellular Signalling·René HuberKorbinian Brand
Jan 16, 2013·Proceedings of the National Academy of Sciences of the United States of America·Yoko HosakaHiroshi Kawaguchi
Jan 24, 2013·Therapeutic Advances in Chronic Disease·Evan Meszaros, Charles J Malemud
Jan 30, 2013·BMC Developmental Biology·Akinori KanClifford J Tabin
May 23, 2013·Annals of the Rheumatic Diseases·D P C de RooyA H M van der Helm-van Mil
Apr 5, 2014·Archivum Immunologiae Et Therapiae Experimentalis·Yanqiu Liu, Bjorn R Olsen
Aug 26, 2014·Cellular Reprogramming·Kathy E O'NeillJonathan M W Slack

❮ Previous
Next ❯

Citations

Dec 14, 2017·Evidence-based Complementary and Alternative Medicine : ECAM·Kun-Yuan ChiuYew-Min Tzeng
Jan 29, 2019·Cellular and Molecular Life Sciences : CMLS·Sheng ZhouMing Pei
Nov 1, 2015·Biochemical Society Transactions·Andrew D Rowan, Gary J Litherland

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.